19.12.2012 Views

European Patent Bulletin 2012/09 - European Patent Office

European Patent Bulletin 2012/09 - European Patent Office

European Patent Bulletin 2012/09 - European Patent Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(A61K) I.1(1)<br />

TUNGEN ZUR PROPHYLAXE VON SCHÄ-<br />

DEN AN DER HAUTEIGENEN DNA UND/<br />

ODER ZUR REPARATUR BEREITS EINGE-<br />

TRETENER SCHÄDEN AN DER HAUT-<br />

EIGENEN DNA<br />

USE OF GLYCYRRHETIC ACID AND/OR<br />

DERIVATIVES THEREOF FOR THE<br />

PRODUCTION OF COSMETIC OR DERMA-<br />

TOLOGICAL PREPARATIONS FOR THE<br />

PROPHYLAXIS OF DAMAGE TO SKIN<br />

DNA AND/OR FOR REPAIRING<br />

PREVIOUSLY INCURRED DAMAGED TO<br />

SKIN DNA<br />

UTILISATION D'ACIDE GLYCYRRHÉTI-<br />

NIQUE ET/OU DE SES DÉRIVÉS POUR<br />

PRODUIRE DES COMPOSITIONS COSMÉ-<br />

TIQUES OU DERMATOLOGIQUES PRÉVE-<br />

NANT LES DOMMAGES DE L'ADN DE LA<br />

PEAU ET/OU RÉPARANT DES<br />

DOMMAGES DÉJÀ SUBIS PAR L'ADN DE<br />

LA PEAU<br />

(71) Beiersdorf AG, Unnastrasse 48, 20253 Hamburg,<br />

DE<br />

(72) KOLBE, Ludger, 21255 Dohren, DE<br />

SCHERNER, Cathrin, 22851 Norderstedt, DE<br />

MANN, Tobias, 22175 Hamburg, DE<br />

AHLHEIT, Sabrina, 22303 Hamburg, DE<br />

HONG, Michael, 10789 Berlin, DE<br />

A61K 8/64 → (51) C07K 5/08<br />

A61K 8/73 → (51) A61K 8/06<br />

A61K 8/81 → (51) A61K 8/23<br />

A61K 8/88 → (51) A61K 8/04<br />

A61K 8/90 → (51) A61K 8/06<br />

A61K 8/92 → (51) A61K 8/06<br />

(51) A61K 9/00 (11) 2 421 503 A1*<br />

A61K 9/12 A61K 31/335<br />

(25) En (26) En<br />

(21) 10715336.3 (22) 23.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA ME RS<br />

(86) GB 2010/050671 23.04.2010<br />

(87) WO 2010/122355 2010/43 28.10.2010<br />

(30) 23.04.20<strong>09</strong> GB <strong>09</strong>06977<br />

23.04.20<strong>09</strong> PCT/GB20<strong>09</strong>/050416<br />

(54) SUBLINGUALE PHARMAZEUTISCHE ZU-<br />

SAMMENSETZUNG MIT EINEM NEUTRA-<br />

LEN ÖL<br />

SUBLINGUAL PHARMACEUTICAL<br />

COMPOSITION COMPRISING A NEUTRAL<br />

OIL<br />

COMPOSITION PHARMACEUTIQUE<br />

SUBLINGUALE COMPRENANT UNE<br />

HUILE NEUTRE<br />

(71) Londonpharma Ltd., Norwich Bioincubator<br />

Norwich Research Park, Colney Lane,<br />

Norwich NR4 7UH, GB<br />

(72) BOOLES, Clive, Norwich Norfolk NR4 7UH,<br />

GB<br />

(74) ip21 Ltd, Central Formalities Department<br />

Lakeside 300 Old Chapel Way, Broadland<br />

Business Park Norwich Norfolk NR7 0WG,<br />

GB<br />

(51) A61K 9/00 (11) 2 421 504 A1*<br />

A61K 31/13 A61K 9/08<br />

(25) En (26) En<br />

(21) 10717263.7 (22) 12.04.2010<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA ME RS<br />

(86) IB 2010/051573 12.04.2010<br />

(87) WO 2010/122442 2010/43 28.10.2010<br />

(30) 21.04.20<strong>09</strong> EP <strong>09</strong>290298<br />

(54) PÄDIATRISCHE LÖSUNGEN MIT EINEM<br />

BETA-BLOCKER<br />

PAEDIATRIC SOLUTIONS COMPRISING A<br />

BETA-BLOCKER<br />

SOLUTIONS PÉDIATRIQUES COMPRE-<br />

NANT UN BÉTABLOQUANT<br />

(71) Pierre Fabre Dermo-Cosmétique, 45, place<br />

Abel-Gance, 92100 Boulogne, FR<br />

(72) CHAUMONT, Christine, F-92100 Boulogne-<br />

Billancourt, FR<br />

CORDOLIANI, Jean-François, F-92100<br />

Boulogne Billancourt, FR<br />

LEVERD, Elie, F-92100 Boulogne Billancourt,<br />

FR<br />

MUGUET, Valérie, F-92100 Boulogne Billancourt,<br />

FR<br />

(74) Hirsch & Associés, 58, avenue Marceau,<br />

75008 Paris, FR<br />

A61K 9/00 → (51) A61K 31/155<br />

A61K 9/00 → (51) A61K 31/167<br />

A61K 9/00 → (51) A61K 31/422<br />

A61K 9/00 → (51) A61K 47/36<br />

(51) A61K 9/06 (11) 2 421 505 A2*<br />

A61K 47/40 A61K 47/34<br />

A61K 39/395 A61P 37/00<br />

A61P 31/00<br />

(25) En (26) En<br />

(21) 10767686.8 (22) 21.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/031866 21.04.2010<br />

(87) WO 2010/123971 2010/43 28.10.2010<br />

(88) 03.03.2011<br />

(30) 22.04.20<strong>09</strong> US 171663 P<br />

(54) HYDROGELE FÜR DIE KOMBINATORI-<br />

SCHE FREISETZUNG VON IMMUNMODU-<br />

LIERENDEN BIOMOLEKÜLEN<br />

HYDROGELS FOR COMBINATORIAL<br />

DELIVERY OF IMMUNE-MODULATING<br />

BIOMOLECULES<br />

HYDROGELS POUR ADMINISTRATION<br />

COMBINATOIRE DE BIOMOLÉCULES<br />

MODULANT L'IMMUNITÉ<br />

(71) Board of Regents, The University of Texas<br />

System, 201 West Seventh Street, Austin, TX<br />

78701, US<br />

(72) SINGH, Ankur, Austin TX 78705, US<br />

ROY, Krishnendu, Austin TX 78750, US<br />

KASTURI, Sudhir, Atlanta GA 30319, US<br />

(74) Pilkington, Stephanie Joan, Potter Clarkson<br />

LLP Park View House 58 The Ropewalk,<br />

Nottingham NG1 5DD, GB<br />

A61K 9/06 → (51) A61K 31/422<br />

A61K 9/06 → (51) A61K 38/17<br />

A61K 9/08 → (51) A61K 9/00<br />

A61K 9/08 → (51) A61K 31/495<br />

A61K 9/107 → (51) A61K 8/06<br />

A61K 9/12 → (51) A61K 9/00<br />

A61K 9/12 → (51) A61K 31/538<br />

36<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>09</strong>/<strong>2012</strong>) 29.02.<strong>2012</strong><br />

A61K 9/127 → (51) A61K 9/133<br />

(51) A61K 9/133 (11) 2 421 506 A2*<br />

A61K 9/127 A61P 35/00<br />

(25) En (26) En<br />

(21) 10767710.6 (22) 21.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/031914 21.04.2010<br />

(87) WO 2010/124004 2010/43 28.10.2010<br />

(88) 17.02.2011<br />

(30) 22.04.20<strong>09</strong> US 171745 P<br />

(54) NANOTRÄGERTHERAPIE ZUR BEHAND-<br />

LUNG VON INVASIVEN TUMOREN<br />

NANOCARRIER THERAPY FOR TREATING<br />

INVASIVE TUMORS<br />

THÉRAPIE PAR NANOSUPPORT POUR<br />

TRAITER DES TUMEURS INVASIVES<br />

(71) Emory University, <strong>Office</strong> of Technology<br />

Transfer 1599 Clifton Road 4th Floor,<br />

Atlanta, GA 30322, US<br />

Georgia Institute Of Technology, 505 10th<br />

Street N.W., Atlanta, GA 30332-0415, US<br />

(72) MUNSON, Jennifer, M., Atlanta GA 303<strong>09</strong>,<br />

US<br />

BELLAMKONDA, Ravi, V., Marietta GA<br />

30062, US<br />

ARBISER, Jack, L., Atlanta GA 30329, US<br />

(74) Hallybone, Huw George, Carpmaels &<br />

Ransford One Southampton Row, London<br />

WC1B 5HA, GB<br />

(51) A61K 9/14 (11) 2 421 507 A1*<br />

A61K 9/68 A61K 31/465<br />

(25) En (26) En<br />

(21) 10716463.4 (22) 26.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) DK 2010/000055 26.04.2010<br />

(87) WO 2010/121619 2010/43 28.10.2010<br />

(30) 24.04.20<strong>09</strong> US 172474 P<br />

(54) KAUGUMMI UND TEILCHENFÖRMIGES<br />

MATERIAL ZUR KONTROLLIERTEN FREI-<br />

SETZUNG VON WIRKSTOFFEN<br />

CHEWING GUM AND PARTICULATE<br />

MATERIAL FOR CONTROLLED RELEASE<br />

OF ACTIVE INGREDIENTS<br />

GOMME À MÂCHER ET MATIÈRE PARTI-<br />

CULAIRE POUR LA LIBÉRATION<br />

CONTRÔLÉE DE PRINCIPES ACTIFS<br />

(71) Fertin Pharma A/S, Dandyvej 19, 7100 Vejle,<br />

DK<br />

(72) PEDERSEN, Kurt, Møller, DK-7323 Give, DK<br />

ANDERSEN, Jette, Baek, DK-7100 Vejle, DK<br />

(74) Mikkelsen, Hans Kristian Saaby, et al,<br />

<strong>Patent</strong>gruppen A/S Arosgaarden Aaboulevarden<br />

31, 8000 Aarhus C, DK<br />

(51) A61K 9/14 (11) 2 421 508 A1*<br />

(25) En (26) En<br />

(21) 10716464.2 (22) 26.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) DK 2010/000056 26.04.2010<br />

(87) WO 2010/121620 2010/43 28.10.2010<br />

(30) 24.04.20<strong>09</strong> US 172474 P<br />

(54) PARTIKELFÖRMIGES MATERIAL ZUR<br />

VERZÖGERTEN WIRKSTOFFFREISET-<br />

ZUNG<br />

PARTICULATE MATERIAL FOR<br />

CONTROLLED RELEASE OF ACTIVE<br />

INGREDIENTS<br />

MATIÈRE PARTICULAIRE POUR LA LIBÉ-<br />

RATION CONTRÔLÉE DE PRINCIPES<br />

ACTIFS<br />

(71) Omya Development AG, Baslerstrasse 42<br />

Postfach 32, 4665 Oftringen, CH

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!